Insulin-like growth factor type 1 (IGF-1) and igf binding protein-3 in patients with ewing sarcoma family of tumors

Cancer

Volumn 92, Issue 11, 2001, Pages 2941-2947

  Toretsky, Jeffrey A ^a,b,e   Steinberg, Seth M ^c   Thakar, Manjusha ^a   Counts, Debra ^b   Pironis, Baiba ^a   Parente, Carrie ^a   Eskenazi, Allen ^a   Helman, Lee ^c   Wexler, Leonard H ^d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e NONE   (United States)

Author keywords

Ewing sarcoma family of tumors; IGFBP 3; Insulin like growth factor 1 (IGF 1); Predictive markers

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TUMOR MARKER;

ARTICLE; BONE MARROW METASTASIS; BONE METASTASIS; BONE TUMOR; CANCER SURVIVAL; EWING SARCOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

BONE NEOPLASMS; DATABASES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; PROGNOSIS; SARCOMA, EWING'S; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035575779     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20011201)92:11<2941::AID-CNCR10072>3.0.CO;2-C     Document Type: Article

References (23)

1. Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors
2. Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma
3. Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity
4. Insulin-like growth factor-I (IGF-I) concentration in 150-kilodalton complexes containing human IGF-binding protein-3 (hIG-FBP-3) after intravenous injection of adult rats with hIG-FBP-3
5. Proteolysis of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in 150-kilodalton IG-FBP complexes by a cation-dependent protease activity in adult rat serum promotes the release of bound IGF-I
6. Role of the insulin-like growth factor family in cancer development and progression
7. Insulin-like growth factor-I and binding protein-3 in relation to childhood leukaemia
8. Insulin-like growth factor I, IGF binding protein 3, and IGFBP protease activity: Relation to anthropometric indices in solid tumours or leukaemia
9. Insulin-like growth factor-I-dependent growth and in vitro chemosensitivity of Ewing's sarcoma and peripheral primitive neuroectodermal turnout cell lines
10. The insulin-like growth factor-I receptor is required for EWS/FLI-1 transformation of fibroblasts
11. Insulin-like growth factor I receptor-mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: A possible therapeutic target
12. Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor
13. Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis
14. Phosphoinositide 3-hydroxide kinase blockade enhances apoptosis in the Ewing's sarcoma family of tumors
15. Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma
16. Sarcomas of the hand and foot: Analysis of local control and functional result with combined modality therapy in extremity preservation
17. A sharper Bonferroni procedure for multiple tests of significance
18. Evaluation of survival data and two new rank order statistics arising in its consideration
19. Non-parametric estimation from incomplete observations
20. Epidemiology of osteosarcoma and Ewing's sarcoma in childhood: A study of 305 cases by the Children's Cancer Group
21. Improved outcome in non-metastatic Ewing's sarcoma (EWS) and PNET of bone with the addition of ifosfamide (I) and etoposide (E) to vincristine (V), Adriamycin (Ad), cyclophosphamide (C), and actinomycin (A): A Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) report
22. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
23. Insulin-like growth factor-I and risk of breast cancer